More than 40 million have died of the virus, which causes AIDS (acquired immunodeficiency syndrome).
Until now it has not been possible to elicit bnAbs by vaccination, she wrote.
After the first immunization, approximately 1 in 10,000 circulating antibodies was a bnAb precursor, he said.
After the second immunization at week 8, approximately 1 in 1,000 circulating antibodies was a bnAb precursor.
The vaccine also had a favorable safety profile, creating no significant adverse events.
So the proof will be in the pudding, so to speak.
He has interviewed doctors and pharmaceutical representatives in the U.S. and abroad.
Rauf lives in Seattle, Washington.
HIV/AIDS
New Injection Offers 100 Percent Protection Against HIV in Women
What Is HIV?
